229 related articles for article (PubMed ID: 29976766)
1. Serum Amyloid A Is an Exchangeable Apolipoprotein.
Wilson PG; Thompson JC; Shridas P; McNamara PJ; de Beer MC; de Beer FC; Webb NR; Tannock LR
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1890-1900. PubMed ID: 29976766
[TBL] [Abstract][Full Text] [Related]
2. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.
O'Brien KD; McDonald TO; Kunjathoor V; Eng K; Knopp EA; Lewis K; Lopez R; Kirk EA; Chait A; Wight TN; deBeer FC; LeBoeuf RC
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):785-90. PubMed ID: 15692094
[TBL] [Abstract][Full Text] [Related]
3. Serum amyloid A is found on ApoB-containing lipoproteins in obese humans with diabetes.
Jahangiri A; Wilson PG; Hou T; Brown A; King VL; Tannock LR
Obesity (Silver Spring); 2013 May; 21(5):993-6. PubMed ID: 23784902
[TBL] [Abstract][Full Text] [Related]
4. [Effects of Chinese herbal medicine Guanxinkang on lipid metabolism and serum C-reactive protein, amyloid A protein and fibrinogen in apolipoprotein E-knockout mice with atherosclerosis].
Mao MJ; Hu JP; Chen FR; Zhang YY; Liu P
Zhong Xi Yi Jie He Xue Bao; 2011 Mar; 9(3):306-12. PubMed ID: 21419084
[TBL] [Abstract][Full Text] [Related]
5. Serum amyloid A facilitates the binding of high-density lipoprotein from mice injected with lipopolysaccharide to vascular proteoglycans.
Chiba T; Chang MY; Wang S; Wight TN; McMillen TS; Oram JF; Vaisar T; Heinecke JW; De Beer FC; De Beer MC; Chait A
Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1326-32. PubMed ID: 21474830
[TBL] [Abstract][Full Text] [Related]
6. Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro.
Cabana VG; Feng N; Reardon CA; Lukens J; Webb NR; de Beer FC; Getz GS
J Lipid Res; 2004 Feb; 45(2):317-25. PubMed ID: 14595002
[TBL] [Abstract][Full Text] [Related]
7. Serum amyloid A is not incorporated into HDL during HDL biogenesis.
Ji A; Wang X; Noffsinger VP; Jennings D; de Beer MC; de Beer FC; Tannock LR; Webb NR
J Lipid Res; 2020 Mar; 61(3):328-337. PubMed ID: 31915139
[TBL] [Abstract][Full Text] [Related]
8. Role of serum amyloid A during metabolism of acute-phase HDL by macrophages.
Artl A; Marsche G; Lestavel S; Sattler W; Malle E
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):763-72. PubMed ID: 10712402
[TBL] [Abstract][Full Text] [Related]
9. The functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activity.
Park KH; Shin DG; Kim JR; Hong JH; Cho KH
Int J Mol Med; 2010 Jan; 25(1):129-36. PubMed ID: 19956911
[TBL] [Abstract][Full Text] [Related]
10. Involvement of CETP (Cholesteryl Ester Transfer Protein) in the Shift of Sphingosine-1-Phosphate Among Lipoproteins and in the Modulation of its Functions.
Kurano M; Hara M; Ikeda H; Tsukamoto K; Yatomi Y
Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):506-514. PubMed ID: 28126827
[TBL] [Abstract][Full Text] [Related]
11. Adenoviral vector-mediated overexpression of serum amyloid A in apoA-I-deficient mice.
Webb NR; de Beer MC; van der Westhuyzen DR; Kindy MS; Banka CL; Tsukamoto K; Rader DL; de Beer FC
J Lipid Res; 1997 Aug; 38(8):1583-90. PubMed ID: 9300780
[TBL] [Abstract][Full Text] [Related]
12. SAA-only HDL formed during the acute phase response in apoA-I+/+ and apoA-I-/- mice.
Cabana VG; Reardon CA; Wei B; Lukens JR; Getz GS
J Lipid Res; 1999 Jun; 40(6):1090-103. PubMed ID: 10357841
[TBL] [Abstract][Full Text] [Related]
13. Serum amyloid A augments the atherogenic effects of cholesteryl ester transfer protein.
Ji A; Trumbauer AC; Noffsinger VP; de Beer FC; Webb NR; Tannock LR; Shridas P
J Lipid Res; 2023 May; 64(5):100365. PubMed ID: 37004910
[TBL] [Abstract][Full Text] [Related]
14. Expression of mouse acute-phase (SAA1.1) and constitutive (SAA4) serum amyloid A isotypes: influence on lipoprotein profiles.
Kindy MS; de Beer MC; Yu J; de Beer FC
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1543-50. PubMed ID: 10845870
[TBL] [Abstract][Full Text] [Related]
15. The positive relationship of serum paraoxonase-1 activity with apolipoprotein E is abrogated in metabolic syndrome.
Dullaart RP; Kwakernaak AJ; Dallinga-Thie GM
Atherosclerosis; 2013 Sep; 230(1):6-11. PubMed ID: 23958245
[TBL] [Abstract][Full Text] [Related]
16. High-density lipoprotein inhibits serum amyloid A-mediated reactive oxygen species generation and NLRP3 inflammasome activation.
Shridas P; De Beer MC; Webb NR
J Biol Chem; 2018 Aug; 293(34):13257-13269. PubMed ID: 29976759
[TBL] [Abstract][Full Text] [Related]
17. The lipidation status of acute-phase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type I.
Marsche G; Frank S; Raynes JG; Kozarsky KF; Sattler W; Malle E
Biochem J; 2007 Feb; 402(1):117-24. PubMed ID: 17034364
[TBL] [Abstract][Full Text] [Related]
18. Human Serum Amyloid a Impaired Structural Stability of High-Density Lipoproteins (HDL) and Apolipoprotein (Apo) A-I and Exacerbated Glycation Susceptibility of ApoA-I and HDL.
Cho KH
Molecules; 2022 Jul; 27(13):. PubMed ID: 35807498
[TBL] [Abstract][Full Text] [Related]
19. Alterations in lipoprotein density classes in infantile visceral leishmaniasis: presence of apolipoprotein SAA.
Bekaert ED; Dole E; Dubois DY; Bouma ME; Lontie JF; Kallel R; Malmendier CL; Ayrault-Jarrier M
Eur J Clin Invest; 1992 Mar; 22(3):190-9. PubMed ID: 1582444
[TBL] [Abstract][Full Text] [Related]
20. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition.
Coetzee GA; Strachan AF; van der Westhuyzen DR; Hoppe HC; Jeenah MS; de Beer FC
J Biol Chem; 1986 Jul; 261(21):9644-51. PubMed ID: 3525531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
